The increasing popularity of next-generation systems has fueled systems and sequencers, but the cost of sequencing - despite price declines - has led to demands for more efficient methods. Exome Sequencing is a widely used NGS technique that sequences all the exons in a genome. Rather than sequencing the entire human genome, only pieces of an individual’s DNA that provide instructions for making proteins are sequenced. These pieces, called exons, are thought to make up roughly 2 percent of a person’s genome. Because most known mutations that cause disease occur in exons, whole-exome sequencing is thought to be an efficient method to identify possible disease-causing mutations.
Exome Sequencing Market provides the following data:
- Exome Sequencing Market, 2019-2024
- Exome Sequencing Market by Region, 2019 (%; US, Europe, ROW)
Table of Contents
1: Executive Summary
2: Exome Sequencing Market
3: Company Profiles
Samples
LOADING...
Companies Mentioned
- 10X Genomics
- Agilent Technologies
- BGI Genomics (formerly Beijing Genome Institute)
- Illumina
- Oxford Nanopore
- Qiagen N.V.
- Roche Diagnostics
- Thermo Fisher Scientific Inc.
